Vital KSK Holdings's EBIT per Share for the
three
months ended in Mar. 2026 was 円48.51.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円239.47.
During the past 12 months, the average EBIT per Share Growth Rate of Vital KSK Holdings was -28.40% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 2.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Vital KSK Holdings's EBIT per Share or its related term are showing as below:
TSE:3151'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -26 Med: 7.3 Max: 31.5
Current: 2.6
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Vital KSK Holdings was 31.50% per year. The lowest was -26.00% per year. And the median was 7.30% per year.
TSE:3151's 3-Year EBIT Growth Rate is ranked worse than 53.33% of 105
companies
in the Medical Distribution industry
Industry Median: 4.2
vs TSE:3151: 2.60
Vital KSK Holdings (TSE:3151) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Vital KSK Holdings EBIT per Share Related Terms
Vital KSK Holdings EBIT per Share Historical Data
* Premium members only.
The historical data trend for Vital KSK Holdings's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円239.47
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vital KSK Holdings (TSE:3151) has a EBIT per Share of 円239.47 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Vital KSK Holdings and its competitors. According to the industry distribution chart, Vital KSK Holdings ranks #56 out of 105 companies in the Medical Distribution industry, placing it in the top 53.3%.
Is Vital KSK Holdings' EBIT per Share too high?
Vital KSK Holdings' current EBIT per Share is 円239.47. Based on the distribution chart, Vital KSK Holdings ranks #56 out of 105 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Vital KSK Holdings has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' EBIT per Share compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Vital KSK Holdings ranks #56 out of 105 companies for EBIT per Share. This places Vital KSK Holdings in the lower half of its industry. The industry median EBIT per Share is 4.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Distribution company?
The median EBIT per Share among Medical Distribution companies is 4.20, based on 105 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Vital KSK Holdings and its competitors. For the Medical Distribution industry, the median EBIT per Share is 4.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vital KSK Holdings's current EBIT per Share is 円239.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vital KSK Holdings (TSE:3151) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,324.76, compared to a current price of 円1,560.00 — trading 17.8% above its estimated fair value. The current EBIT per Share is 円239.47. Vital KSK Holdings' overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Vital KSK Holdings (TSE:3151), the current EBIT per Share is 円239.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vital KSK Holdings (TSE:3151) Overvalued in 2026?
Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued.
The current stock price of 円1,560.00 is trading 17.8% above its estimated GF Value™ of 円1,324.76.
GuruFocus considers Vital KSK Holdings to be Modestly Overvalued.
Key valuation signals for TSE:3151:
EBIT per Share: 円239.47
GF Value™: 円1,324.76 vs. price of 円1,560.00 (17.8% above fair value)
No single metric tells the full story. See the TSE:3151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
70GF Score
Get the complete analysis for TSE:3151
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3151 has been successfully added to your 
